MORTEZA NADJAFI: Open Payments
NPI 1912954660 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,890 in 88 payments from 23 companies in 2025. Trend: 2023 $1,649 · 2024 $1,369 · 2025 $3,890
Food & beverage: $2,387Travel & lodging: $1,503
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $2,281 |
| Corium, LLC | 10 | $224 |
| E.R. Squibb & Sons, L.L.C. | 4 | $183 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
| ABBVIE INC. | 10 | $139 |
| ACADIA Pharmaceuticals Inc | 2 | $129 |
| Axsome Therapeutics, Inc. | 5 | $124 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Bausch Health US, LLC | 3 | $55 |
Products named: INGREZZA, Azstarys, COBENFY, NUPLAZID, VRAYLAR, Auvelity, REXULTI, FANAPT.
Industry payments across FL — which companies pay providers there.
